GALR2
Gene Information
- Official Symbol: GALR2
- Official Name: galanin receptor 2
- Aliases and Previous Symbols: N/A
- Entrez ID: 8811
- UniProt: O43603
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: N/A
- UniProt Summary: Receptor for the hormone galanin and GALP. Receptor for the hormone spexin-1 (PubMed:24517231). The activity of this receptor is mediated by G proteins that activate the phospholipase C/protein kinase C pathway (via G(q)) and that inhibit adenylyl cyclase (via G(i)). {ECO:0000269|PubMed:24517231, ECO:0000269|PubMed:25691535, ECO:0000269|PubMed:9480833, ECO:0000269|PubMed:9685625, ECO:0000269|PubMed:9832121, ECO:0000269|PubMed:9880084}.
Pfam Domains GO Terms
Pfam Domains
| 7tm 1 |
| 7TM GPCR Srsx |
GO Terms
| positive regulation of large conductance calcium-activated potassium channel activity |
| galanin-activated signaling pathway |
| regulation of large conductance calcium-activated potassium channel activity |
| galanin receptor activity |
| negative regulation of adenylate cyclase activity |
| negative regulation of cyclase activity |
| negative regulation of lyase activity |
| neuropeptide binding |
| positive regulation of potassium ion transmembrane transporter activity |
| regulation of adenylate cyclase activity |
| positive regulation of potassium ion transmembrane transport |
| G protein-coupled peptide receptor activity |
| peptide hormone binding |
| regulation of cyclase activity |
| positive regulation of potassium ion transport |
| regulation of lyase activity |
| regulation of potassium ion transmembrane transporter activity |
| inositol phosphate metabolic process |
| positive regulation of cation channel activity |
| regulation of potassium ion transmembrane transport |
| feeding behavior |
| phospholipase C-activating G protein-coupled receptor signaling pathway |
| regulation of potassium ion transport |
| positive regulation of ion transmembrane transporter activity |
| neuropeptide signaling pathway |
| polyol metabolic process |
| positive regulation of transporter activity |
| adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| positive regulation of cation transmembrane transport |
| cAMP-mediated signaling |
| positive regulation of ion transmembrane transport |
| phosphatidylinositol metabolic process |
| regulation of cation channel activity |
| cyclic-nucleotide-mediated signaling |
| cilium |
| positive regulation of transmembrane transport |
| adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| muscle contraction |
| regulation of ion transmembrane transporter activity |
| learning or memory |
| regulation of transmembrane transporter activity |
| positive regulation of ion transport |
| regulation of transporter activity |
| positive regulation of cytosolic calcium ion concentration |
| cognition |
| muscle system process |
| glycerophospholipid metabolic process |
| alcohol metabolic process |
| regulation of cytosolic calcium ion concentration |
| regulation of cation transmembrane transport |
| second-messenger-mediated signaling |
| phospholipid metabolic process |
| glycerolipid metabolic process |
| regulation of metal ion transport |
| cellular calcium ion homeostasis |
| calcium ion homeostasis |
| organic hydroxy compound metabolic process |
| cellular divalent inorganic cation homeostasis |
| regulation of ion transmembrane transport |
| divalent inorganic cation homeostasis |
| cellular metal ion homeostasis |
| regulation of transmembrane transport |
| behavior |
| metal ion homeostasis |
| cellular cation homeostasis |
| cellular ion homeostasis |
| neuron projection development |
| regulation of ion transport |
| cation homeostasis |
| inorganic ion homeostasis |
| cellular chemical homeostasis |
| ion homeostasis |
| negative regulation of catalytic activity |
| neuron development |
| organophosphate metabolic process |
| cellular homeostasis |
| cellular lipid metabolic process |
| positive regulation of transport |
| neuron differentiation |
| chemical homeostasis |
| plasma membrane bounded cell projection organization |
| negative regulation of molecular function |
| cell projection organization |
| lipid metabolic process |
| positive regulation of transcription by RNA polymerase II |
| G protein-coupled receptor signaling pathway |
| nervous system process |
| integral component of plasma membrane |
| generation of neurons |
| positive regulation of transcription, DNA-templated |
| neurogenesis |
| positive regulation of nucleic acid-templated transcription |
| positive regulation of RNA biosynthetic process |
| homeostatic process |
| cell development |
| intracellular signal transduction |
| positive regulation of RNA metabolic process |
| small molecule metabolic process |
| positive regulation of molecular function |
| regulation of transport |
| positive regulation of nucleobase-containing compound metabolic process |
| positive regulation of macromolecule biosynthetic process |
| system process |
| positive regulation of cellular biosynthetic process |
| positive regulation of gene expression |
| positive regulation of biosynthetic process |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
| Screen | Score |
|---|---|
| Adefovir 20μM R07 exp332 | -1.89 |
| All-trans-Retinoic-Acid 8μM R07 exp333 | -1.72 |
| SGC0946 7μM R03 exp151 | -1.71 |
Most Correlated Genes in Chemogenomics
No correlation found to any other genes in chemogenomics.
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 0/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Essentiality in NALM6
- Essentiality Rank: 15922
- Expression level (log2 read counts): -2.84
Expression Distribution
GALR2 Expression in NALM6 Cells: -2.84